GlassScriptPhysician profile
Carolyn Whitney
NPI 1588658173
$3,167.58
in general payments reported to CMS, 2019-2025
15 companies · $903 in 2025
The $903 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $158 · 2021: $185 · 2022: $652 · 2023: $483 · 2024: $529 · 2025: $903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,915.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,114.00 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $412.10 | 2019-2024 | Trelegy Ellipta, Bexsero |
| Novo Nordisk INC | $359.27 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $247.99 | 2023-2025 | |
| Dexcom, INC. | $228.98 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Daiichi Sankyo INC. | $221.24 | 2021-2023 | Injectafer |
| Merck Sharp & Dohme LLC | $155.63 | 2019-2021 | |
| Pfizer INC. | $153.46 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $119.26 | 2025 | Gore Excluder Aaa Endoprosthesis |
| Dynavax Technologies Corporation | $83.72 | 2024-2025 | Heplisav-B |
| Exact Sciences Corporation | $15.12 | 2025 | The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $15.02 | 2025 | Zoryve |
| Takeda Pharmaceuticals U.S.A., INC. | $14.20 | 2020 | |
| Lilly USA, LLC | $13.80 | 2022 | |
| Shield Therapeutics INC | $13.79 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Whitney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.